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Abstract:  
Background: Mitochondria contain extra-nuclear genome in the form of mitochondrial DNA 
(MtDNA), damage to which can lead to inflammation and bioenergetic deficit. Changes in 
MtDNA levels are increasingly used as a biomarker of mitochondrial dysfunction. We 
previously reported that in humans, fragments in the nuclear genome known as nuclear 
mitochondrial insertion sequences (NumtS) affect accurate quantification of MtDNA. In the 
current paper our aim was to determine whether mouse NumtS affect the quantification of 
MtDNA and to establish a method designed to avoid this.  
Methods: The existence of NumtS in the mouse genome was confirmed using blast N, 
unique MtDNA regions were identified using FASTA, and MtDNA primers which do not co-
amplify NUMTs were designed and tested.  MtDNA copy numbers were determined in a 
range of mouse tissues as the ratio of the mitochondrial and nuclear genome using real time 
qPCR and absolute quantification.   
Results: Approximately 95% of mouse MtDNA was duplicated in the nuclear genome as 
NumtS which were located in 15 out of 21 chromosomes. A unique region was identified and 
primers flanking this region were used. MtDNA levels differed significantly in mouse tissues 
being the highest in the heart, with levels in descending order (highest to lowest) in kidney, 
liver, blood, brain, islets and lung.  
Conclusion: The presence of NumtS in the nuclear genome of mouse could lead to erroneous 
data when studying MtDNA content or mutation. The unique primers described here will 
allow accurate quantification of MtDNA content in mouse models without co-amplification 
of NumtS. 
 
 
Keywords: mitochondrial DNA, mitochondrial pseudogenes, NumtS, real time PCR, mouse 
mitochondrial genome 
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1. Introduction 
Mitochondria are eukaryotic organelles in the cytosol of eukaryotic cells whose main 
function is to generate energy in the form of ATP, and regulate key cellular functions 
including the redox state of cells, apoptosis, calcium homeostasis, cellular differentiation and 
growth  (1, 2). The numbers of mitochondria can vary from hundreds to thousands per cell, 
depending on the cell‟s bio-energetic requirements (3, 4).  
Mitochondria contain their own circular DNA genome, and as each mitochondrion can 
contain 2-10 copies of 5-μm circular mitochondrial DNA genome, cells with mitochondria 
contain hundreds to thousands of copies of MtDNA per nuclear genome (5). MtDNA is 
transcribed and translated within the mitochondrion and its replication is independent of 
phase-restricted nuclear DNA and the cell cycle  and responds to physiological stimuli (6).  It 
is generally assumed that MtDNA level correlate with both mitochondrial function, and the 
number of mitochondria in the cell (3, 4).  However, altered MtDNA levels associated with 
disease in blood samples, body fluids, and cells and tissues have been reported in a wide 
range of human disease  leading to the hypothesis that changes in MtDNA content may be 
indicative of mitochondrial dysfunction (7). Alterations in MtDNA may be indicative of 
altered metabolic activity; or they can also be indicative of potential inflammatory pathways, 
as MtDNA has emerged as a mediator of inflammation as if in the wrong place, it can 
activate immune responses  because of the resemblance to bacterial DNA (8, 9). 
The mitochondrial genome comprises of 16,569 base pairs (bp) in humans and between 
16,301-16,769 bp in mouse (10). MtDNA is highly conserved between organisms and 
encodes 37 genes; 13 mRNAs, 2 rRNAs and 22 tRNAs  and 1 non-coding D-loop region (6). 
The remainder of >1500 mitochondrial proteins are encoded by nuclear genome, transcribed 
into mRNAs, translated on cytoplasmic ribosomes, and imported into the mitochondrion (11).  
Fragments of mitochondrial genome are present in the nuclear genome in the form of 
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pseudogenes called NumtS (Nuclear mitochondrial insertion sequences), which have been 
found to lead to erroneous identification of mitochondrial heteroplasmies (12, 13). 
The quality and quantity of MtDNA is widely employed as a determinant of mitochondrial 
activity. The most commonly used method used measure MtDNA content in a cell is to 
quantify the mitochondrial genome versus nuclear genome ratio, termed Mt/N (7, 14-16). The 
problem with MtDNA quantification methods is that co-amplification of NumtS is likely to 
lead to erroneous data when measuring MtDNA content or the presence of MtDNA 
mutations. Furthermore, southern blot based methods are still in use (17) which are likely to 
lead to cross hybridisation of NumtS rather than specifically MtDNA. To overcome this 
issue, we previously developed a PCR-based method by identifying unique regions in the 
human mitochondrial genome not duplicated in the nuclear genome  to accurately quantify 
MtDNA from human samples (16). However, a similar approach has not been described for 
mouse MtDNA and there is little information in the literature about whether mouse MtDNA 
is present as NumtS in the nuclear genome. Therefore in the current paper our objective was 
to investigate the presence of NumtS in the mouse nuclear genome, define regions in the 
mouse mitochondrial genome which are unique and not duplicated in the nuclear genome, 
and to use primers designed to these in order to accurately measure MtDNA copy numbers in 
a range of mouse tissues. 
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2. Material and methods 
2.1.Identification of unique regions of mitochondrial genome and primer design 
The duplication of the mitochondrial genome in the nuclear genome was detected using 
BLAST version 2.2.32 (http://www.ncbi.nlm.nih.gov) (18). Unique regions were identified in 
the mouse mitochondrial sequence, retrieved from ENSEMBL (19) using FASTA version 
3.5.2.7 (20) as described previously (16). To measure nuclear DNA, primers against single 
copy nuclear gene, Beta-2 microglobulin (B2M) were designed (Table 1). 
2.2.Animals  
Male C57BL/6 mice (Charles River, Margate, UK) were kept in standard conditions. All 
animal procedures were approved by our institution‟s Ethics Committee and carried out under 
license, in accordance with the UK Home Office Animals (Scientific Procedures) Act 1986. 
Animals were sacrificed when they reached 3 months of age according to approved protocols 
and tissue and blood samples of these mice were collected and immediately snap frozen. 
Samples were stored at -80⁰C. 
2.3. Genomic DNA preparation 
Tissue samples were homogenized using TissueLyser (Qiagen) in order to eliminate cross-
contamination. Total genomic DNA was extracted using the DNeasy Blood & Tissue kit 
according to manufacturer‟s instruction (Qiagen) (16). Before proceeding to qPCR, the DNA 
template was subjected to the pre-treatment (DNA template shearing using bath sonicator 
Kerry, Pulsatron 55 which uses 38kHz+/-  for 10 minutes) as described previously (15, 16) in 
order to avoid dilution bias. The template concentration was determined using NanoDrop and 
adjusted to 10ng/μl.  To avoid errors arising from repeated freeze thaw cycles DNA samples 
were kept at 4
o
C for the duration of study. 
2.4. Real-time PCR 
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MtDNA content was assessed by absolute quantification using real time PCR.  Primers for 
mouse MtDNA (mMitoF1, mMitoR1) and mouse B2M (mB2MF1, mB2MR1) were used to 
amplify the respective products from mouse genomic DNA (Table1). PCR products were 
purified and used to prepare dilution standards for both amplicons and the range of dilutions 
used were 10
2
-10
8copies per 2μl to allow absolute quantification. MtDNA copy number per 
cell were determined from template DNA by carrying out qPCR in a total volume of 10μl, 
containing 5μl of Quantifast SYBR Master Mix (Qiagen), 0.5μl of forward and reverse 
primer (400nM final concentration each), 2μl template DNA and 2μl of DNase free water. 
The reactions were performed in Roche LightCycler (LC) 480 instrument using the following 
protocol: pre-incubation at 95°C for 5 min (1 cycle); denaturation at 95°C for 10 s, annealing 
and extension at 60°C for 30 s (repeat denaturation and extension steps for 40 cycles), 
melting at 95°C for 5 s, 65°C for 60 s, and 95°C continues (melt curve analysis -1 cycle) and 
the last step, cooling at 40°C for 30s. The specificity of the primers (one PCR product 
amplified) was confirmed as a single melt peak and single band when electrophoresed on 2% 
agarose gel for both amplicons (not shown). qPCR efficiency calculated from the slope was 
between 95-105% with co-efficiency of reaction R
2
 =0.98-0.99.  
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
7 
 
3. Results  
3.1  Identification of nuclear mitochondrial insertion sequences (NumtS) in 
the mouse genome 
We used the mouse mitochondrial genome sequence (accession number NC_005089.1) 
derived from Mus musculus (21) and which shows high sequence identity with mitochondrial 
genomes from commonly used mouse strains,  to search for similar sequences in the mouse 
nuclear genome reference sequence using blast (NCBI, http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Mus Musculus). The resulting data showed that many regions of the mouse mitochondrial 
genome showed strong sequence identity (>90%) with regions located in the nuclear genome, 
suggesting that these regions contain NumtS (Figure 1a). NumtS were found in 15 out of 21 
mouse chromosomes and ranged from 30bp to 4654bp (Figure 1b). More than 95% of the 
mouse mitochondrial genome was present in varying lengths and different positions in the 
mouse nuclear genome.   
3.2  Design of unique primers to amplify mouse mitochondrial DNA  
The mouse mitochondrial genome sequence was split into overlapping fragments of 150bp 
length with a 50bp overlap at each end, and each fragment was used as a query sequence in a 
FASTA search against the entire mouse genome, one chromosome at a time (both strands). 
Each candidate „unique‟ sequence was tested using BLAST to ensure programmatic 
accuracy. Using this approach, a unique mitochondrial sequence of 211bp was identified, this 
region flanks position 1323-1447 of the mouse mitochondrial genome (accession number 
NC_005089.1), and accounts for less than 1.5% of the whole mouse mitochondrial genome. 
In addition, we found that between positions 200-3000 of the mouse mitochondrial genome, 
the frequency and length of NumtS were smaller and presence of other unique regions might 
be possible. We used the sequence at position 1323-1447 to design primers mMitoF1 and 
mMitoR1 which do not co-amplify NumtS (Table 1).   
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3.3 Absolute quantification of mouse mitochondrial DNA  
The primers designed above were used to test the accuracy and reproducibility of the assay 
using mouse kidneys (Figure 2). Total DNA isolated from kidneys of C57BL/6 mice (n=18) 
was used as template for amplification and quantification of the two target regions using 
mmito and mB2M primers (Table 1). The template DNA was sonicated, the concentration 
adjusted to 10ng/ul, and qPCR was carried out in triplicate for 10 ng and 1 ng per template, 
the resulting averages representing 6 measurements per original sample for each gene were 
used to calculate the mitochondrial genome to nuclear genome ratio in the samples (Table 2) 
and to test the accuracy of the assay (Figure 2a). The amount of mitochondrial and nuclear 
DNA in 10ng and 1ng, using values extrapolated from the standards curves, is shown in 
figures 2b and 2c respectively and shows that as expected, 10 fold reduction of the amount of 
template used results in 10fold reduction of both MtDNA and B2M, i.e removal of the 
dilution effect which can skew the Mt/N ratio [16]. The Mt/N values in the samples remain 
constant (Figure 2a) and melting curve analysis and DNA sequencing confirmed the 
specificity of the qPCR reactions (not shown).  
We next used the assay to determine the accurate amount of MtDNA in a range of mouse 
tissues and blood samples (Figure 3) as the mitochondrial genome to nuclear genome ratio. 
MtDNA  was detected in all samples.  The highest detected MtDNA copy number was in the 
heart (1273 copies/nuclear genome) followed by the kidney (332 copies/nuclear genome) and 
surprisingly, the lowest was in lung and islets (6 and 33 copies/ nuclear genome respectively, 
Figure 3). 
4. Discussion  
In this study, we have described the measurement of mouse MtDNA content using real-time 
qPCR and primers targeting a unique sequence in the mouse mitochondrial genome without 
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co-amplification of mouse NumtS. We showed that more than 95% of the mitochondrial 
genome is duplicated in the mouse nuclear genome in the form of NumtS, with the same 
MtDNA region being present in several chromosomal regions within the nuclear genome. 
Our observation is in accordance to a report by Richly and Leister, who demonstrated that 
mouse and human mitochondrial genomes have the highest ratio of NumtS  in the nuclear 
genome (99% and 98 % respectively) when compared with other eukaryotic genomes which 
generally have less than 50% of the transferred MtDNA pseudogenes (22). NumtS are usually 
fragmented and equally distributed among chromosomes (23). Calabrese at al. reported  that 
mouse NumtS are shorter, but much more conserved when compared to pseudogene 
sequences in chimpanzee and rhesus monkey (24).  
We detected mouse NumtS in 15 out of 21 mouse chromosomes with the largest mouse Numt 
being identical to ~30% of mouse mitochondrial genome. The region of the mitochondrial 
genome located between position 200 and 3000 contained lower numbers of NumtS which 
were also shorter in length allowing us to identify a unique region at position 1323 to 1447 
which could be utilised for qPCR.  The demonstration of NumtS in the mouse genome should 
be taken into account when detecting either mitochondrial mutations or measuring MtDNA 
content. The presence of NumtS in the nuclear genome has in the past led to erroneous 
reports of MtDNA mutations and of association with diseases (12, 13). It can also lead to 
errors  in determination of MtDNA content when using primers targeting both MtDNA and 
NumtS  (13). Many studies use primers designed to target mitochondrial genes which are part 
of OXPHOS system (25-27, 28. However, in mice,  the entire sequences of cytochrome c 
oxidase I, II and III (Cox1, Cox2 and Cox 3), and 99% of the cytochrome b (Cyt b) sequence 
are duplicated in the mouse nuclear genome, and therefore likely to lead to erroneous data. It 
may be argued that co-amplification of mitochondrial NumtS may have no significant effect 
on overall results since some cells contain thousands of copies of MtDNA and only two 
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copies of nDNA. However, when small disease associated changes are being reported 
potential errors could skew data, especially when one considers that  the extraction method 
(29),  storage and pre-treatment of the template (16) can cause an unequal distribution of the 
nuclear DNA and MtDNA in  samples (7). Many NumtS are presented several times in the 
nuclear genome and it has been suggested that their copy numbers can change with disease. 
For example, Caro et al., (2010)  showed that mitochondrial sequences corresponding to 
cytochrome oxidase III and 16srRNA were present in purified nuclei of liver and brain tissues 
from young and old rats. Interestingly, these regions contained the same SNPS found in the 
mitochondrial genome of the same age and their copy numbers increased with age. This study 
suggests that NUMTs are variable with age and is an additional reason to avoid using PCR 
procedures which amplify NUMTs (30). We suggest that attempts should be made to 
minimise experimental errors by ensuring that the target sequences are specific and that the 
protocols employed do not affect data due to co-amplification of NumtS, dilution bias or 
storage issues as described earlier (16, 29). Our mtDNA quantification approach has 
undergone rigorous quality control; The assay is carried out at optimized template 
concentrations after template pre-treatment to enhance accuracy, ensuring that the “dilution 
effect” caused by the differing solubility of the mitochondrial genome versus the nuclear 
genome is minimized. The issues around template preparation and handling stem from the 
differing genome sizes, the mitochondrial genome is small and circular, the nuclear genome 
is large and comprised of linear fragments, and the two genomes have differing properties in 
solution resulting in skewing of the ratio. Therefore in the assay each target was measured 
using absolute quantification in triplicate at 2 different dilutions. The assay shows >99% 
primer specificity, quantity CV of <5%, <5% plate to plate variability and has been validated 
by comparison of output from >4 independent lab workers. 
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MtDNA content has been shown to be altered in the variety of diseases in tissues and in 
circulating cells in human studies,  and is a commonly used marker of mitochondrial health in 
animal studies, including diabetes (31-33), Parkinson‟s disease (34), and cancer (35).  
The unique primers which we describe here do not co-amplify mouse NumtS and therefore 
can be used to determine absolute copy numbers of MtDNA in a range of mouse tissues as 
well as in conditions of disease. We found that the tissues with the highest MtDNA content 
were heart and kidney, and surprisingly, the lowest MtDNA content was found in lung, being 
even lower than whole peripheral blood. These findings correlate with results reported by 
others in human (36) and in rat tissues (37). It would be interesting to determine if MtDNA 
content in different organs and cell types is indicative of bioenergetic function, and whether 
tissues such as heart and kidney, which contain the highest levels of MtDNA, are more prone 
to MtDNA damage and MtDNA mediated inflammation.  
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Table 1. Oligonucleotides used in the study. 
Accession 
number 
Primer Oligonucleotide sequence (5'->3') Product 
size (bp) 
NC_005089.1 
mMitoF1 CTAGAAACCCCGAAACCAAA 
125 
mMitoR1 CCAGCTATCACCAAGCTCGT 
NC_000068.7 
mB2MF1 ATGGGAAGCCGAACATACTG 
177 
mB2MR1 CAGTCTCAGTGGGGGTGAAT 
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Table 2. Absolute quantification of mitochondrial DNA and nuclear DNA: comparison of 
data from two different dilutions of template DNA obtained from mouse kidneys. Columns 3-
5 represents replicates of mitochondrial gene copy number, columns 7-9 represents replicates 
of B2M copy number. Mitochondrial DNA content (MT/N ratio) is shown in column 11 
 
Animal 
number  
DNA 
conc. 
(ng) 
Mito1  Mito2  Mito 3  Average B2M 
1 
B2M2 B2M3 Average Mt/N  
1 10 787000 801000 690000 850463 5230 4770 4460 4027 158 
2 10 1330000 1330000 1400000 6340 5360 6590 222 
3 10 1580000 2130000 ND 3370 3300 5490 458 
4 10 1120000 1200000 1110000 5490 7060 6550 180 
5 10 637000 936000 737000 3300 3850 2720 234 
6 10 913000 871000 1230000 5880 5120 5010 188 
7 10 938000 672000 1210000 4730 4460 5590 191 
8 10 925000 925000 1200000 5850 6400 6000 167 
9 10 538000 394000 542000 2450 1690 1040 285 
10 10 714000 688000 471000 3100 2630 2420 230 
11 10 645000 457000 394000 1810 989 1060 388 
12 10 271000 379000 517000 2016 1897  199 
13 10 1100000 933000 911000 6860 6660 6150 150 
14 10 585000 585000 409000 3620 2860 4630 142 
15 10 1000000 ND 860000 7720 7600 6720 127 
16 10 453000 406000 412000 1500 1590 1490 278 
17 10 1300000 1130000 1140000 2280 2770 2830 453 
18 10 452000 412000 370000 1750 2340 2120 199 
1 1 99100 84700 85300 118469 291 422 561 503 211 
2 1 166000 180000 244000 707 1070 1110  204 
3 1 142000 157000 177000 376 202 256 571 
4 1 99400 100400 99400 823 768 849 123 
5 1 112000 149000 154000 460 540 679 247 
6 1 181000 170000 156000 537 877 475 268 
7 1 84700 71900 118000 477 587 838 144 
8 1 252000 196000 209000 727 605 727 319 
9 1 20300 77500 60500 179 133 181 321 
10 1 68500 74800 72600 300 345 395 208 
11 1 65400 62500 60300 276 233 209 262 
12 1 67500 65000 63300 163 240 259 296 
13 1 131000 126000 213000 621 388 531 305 
14 1 146400 139300 151500 640 538 673 236 
15 1 142000 138000 185000 878 1180 769 164 
16 1 65200 68700 61400 309 211 259 251 
17 1 150000 112000 177000 450 429 430 335 
18 1 44200 42200 58300 348 394 254 145 
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Figure legends: 
Figure 1. Duplication of mouse mitochondrial genome in nuclear genome. (a) The thick 
red line (query) representing the mitochondrial genome sequence accession number 
NC_005089.1, was blasted against the reference sequence of the mouse genome using blastn, 
the first 40 best matching sequences are shown, top 5 red lines being an exact match to the 
mitochondrial genome, whereas the remaining 35 lines are regions of the nuclear genome 
showing a high degree of identity. The colour key for alignment scores is given at the top of 
the figure with red being the highest alignment score. (b) Mitochondrial pseudogenes in the 
nuclear genome are shown as bars against the relevant mouse chromosome, the extent of the 
homology is shown as a colour code indicated in and the number of hits is shown in red 
numbers below the chromosome number shown in blue.  
 
Figure 2 Assay validation using different concentration of template. Mouse kidneys were 
collected from C57BL/6 mice (n=18), total DNA was extracted, pre-treated and diluted to 
10ng/μl and 1ng/μl. MtDNA content was quantified using absolute quantification with real-
time qPCR. Data are shown for both 10ng and 1ng dilutions as mean values ± SEM derived 
from Table1 (a) MtDNA content (Mt/N) calculated as the ratio of mitochondrial genome to 
nuclear genome  (b) Absolute MtDNA copy numbers without normalisation to nuclear 
genome (c) Absolute nuclear DNA copy numbers.   
 
Figure 3 Mitochondrial DNA copy numbers in mouse tissues. Tissue samples were 
collected from healthy control C57BL/6 mice. Following DNA extraction and template pre-
treatment, MtDNA content was assessed as the ratio of mitochondrial genome to nuclear 
genome (Mt/N) using real-time qPCR. Data are shown as mean ± SEM, n =3-4 (brain and 
islets samples), n=6 for rest of tissues. 
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Figure 1 Duplication of mitochondrial genome in nuclear genome.  
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Figure 2 Assay validation using different concentration of template 
a)   
 
 
 
     b) 
 
 
 
 
c)  
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Figure 3. Mitochondrial DNA copy numbers in mouse tissues.  
 
 
 
 
 
  
MtDNA range 
(copy number)  
157- 
1273 
332- 
440 
235- 
372 
80- 
344 
81- 
208 
33- 
51 
9- 
60 
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Highlights 
 DNA fragments identical to the >95% of the mouse mitochondrial genome are present 
as nuclear mitochondrial insertion sequences (NumtS) in the nuclear genome 
 Unique regions in the mouse mitochondrial genome  which do not co-amplify NumtS 
were identified  
 Primers described in this paper will allow the use of real time qPCR for determination 
of MtDNA content in different mouse tissues in differentiation and disease without 
coamplification of numtS 
  MtDNA content was measured in a range of tissues and was the highest in the heart 
and the kidney 
